In a 10-year consecutive series of 263 allogeneic bone marrow transplant recipients, we identified five cases (1.9%) of invasive mucormycosis. Only one infection occurred within the first 100 days after transplantation, while the remainder complicated the late post-transplant course (median day of diagnosis: 343). Sites of infection were considered 'non-classical' and included pulmonary, cutaneous and gastric involvement. No case of fungal dissemination was observed. Mucormycosis was the primary cause of death in three of the five patients. Corticosteroid-treated graft-versus-host disease, either acute or chronic, or severe neutropenia were present in all cases. However, compared with a matched control population, the most striking finding was the demonstration of severe iron overload in each of the mucormycosis patients. The mean level of serum ferritin, transferrin saturation and number of transfused units of red cells (2029 g/l, 92% and 52 units, respectively) in the study group is significantly higher compared with the control group (P Ͻ 0.05). The difference with other risk groups for mucormycosis, including deferoxamine-treated dialysis patients and acidotic diabetics, was analyzed in view of the possible pathogenic role of iron. Although these infections are often fatal, limited disease may have a better prognosis if diagnosed early and treated aggressively.
old bread and soil, are most frequently encountered in human pathology. 1 Following the inhalation of airborne spores, primary infection usually develops in the upper and lower respiratory tract. Untreated, these mycoses are characterized by rapid progression via extension to contiguous sites and via hematogenous dissemination. The clinico-radiological features are virtually indistinguishable from other invasive filamentous mycoses and result from hyphal angio-invasion leading to thrombosis and infarction of surrounding tissue and extensive hemorrhage. [1] [2] [3] [4] [5] [6] Underlying medical conditions and risk factors may influence the portal of entry and hence the presenting clinical syndrome. The rhinocerebral form is classically seen in poorly controlled diabetes, especially with ketoacidosis, while invasive pulmonary disease is most frequently diagnosed in neutropenic patients. Isolated gastrointestinal invasion is a rare condition associated with severe protein malnutrition while mucormycosis of the skin and soft tissue develops in burns patients or after local (sustained) trauma. Isolated cerebral mucormycosis has been reported in drug addicts and AIDS patients. 7 Finally, acute and rapidly progressive dissemination can be seen in severely immunocompromised hosts. 2 The major predisposing factors for mucormycosis are non-specific and well known with fungal infection in general, and include prolonged granulocytopenia, steroid administration, broadspectrum antibiotic therapy, hyperglycemia and immunosuppressive therapy. 8 Also, since 1987, a striking association between the occurrence of mucormycosis in dialysis patients and the use of deferoxamine (DFO) for the treatment of iron and/or aluminium overload has been observed and confirmed by an international registry. 9 This singular association, however, has seldom been described in DFO-treated patients with normal renal function.
The occurrence of mucormycosis after BMT has only been described sporadically. 10, 11 We report five cases in allogeneic transplant recipients and review the possible pathogenic role of iron in the development of mucormycosis.
Patients and methods
The medical records of a consecutive series of 263 patients who underwent allogeneic bone marrow transplantation between 1987 and 1997 at the University Hospital Gasthuisberg, Leuven, were reviewed retrospectively for the occurrence of invasive mucormycosis during the post-transplant period. A diagnosis of proven invasive mucormycosis was based on (1) histopathological demonstration of tissue invasion on biopsy or autopsy specimens, disclosing the characteristic broad, irregularly shaped non-septated hyphae with right angle branching, and confirmed by a positive culture from the same site; or (2) a positive culture from an otherwise sterile body fluid. Invasive organ infection was defined as the involvement of one organ, while dissemination included involvement of at least two noncontiguous organs. Histopathological findings consistent with mucormycosis but without culture confirmation were considered as probable infection. The isolation of Mucorales species from a non-sterile body fluid (including sputum and BAL fluid) without histopathological confirmation was not analyzed. All samples were processed by standard methods for mycological diagnosis. Tissue invasion was visualized by periodic-acid-Schiff and/or Gomori-methenamine-silver staining.
Information was obtained on patient characteristics, type and treatment of underlying disorder, underlying risk factors such as diabetes mellitus, acidosis, steroid administration, neutropenia and immunosuppressive therapy, mucormycosis (type, diagnosis, therapy and outcome), therapy with deferoxamine, renal function, transfusion policy and iron status.
The diagnosis of iron overload was based on serum ferritin levels exceeding 1000 g/l (taken before the infectious episode), transferrin saturation above 90% and/or the presence of stainable iron on liver, spleen and bone marrow. All histological sections were stained by routine methods and graded for the presence of iron by semiquantitative estimation (from 0 to ϩϩϩ) by one of the authors (EV). To assess the impact of iron overload in the development of mucormycosis, a case-control study was conducted using randomly selected controls that were matched to cases at a 2:1 ratio. The Student's t-test was used to compare variables (software program SAS).
Mucormycosis was considered the cause of death when histological examination of a major organ that clinically failed disclosed hyphal involvement in the absence of other pathogens.
Results
Invasive mucormycosis was detected in five patients (1.9%) during the post-transplant period. Table 1 summarizes selected characteristics of the patients and their infection. Iron parameters of all five are also depicted in Table 1 . Mean serum ferritin level, transferrin saturation and number of red cell transfusions (given from day 1) were significantly higher in case patients compared with matched control patients: 2029 g/l vs 608 g/l (P = 0.0185), 92% vs 63% (P = 0.0001) and 52 vs 26 units (P = 0.0001), respectively.
Case reports

Case 1
A 48-year-old man underwent an uncomplicated HLA-identical sibling bone marrow transplant for a first relapse of a common acute lymphoblastic leukaemia (diagnosed 1 year before). In June, 1 year later, the patient was readmitted to hospital because of a second relapse for which he received salvage chemotherapy including vindesine and methylprednisolone. The serum iron level at that time was 121 g/dl, the total iron binding capacity 121 g/dl and the transferrin saturation 100%. A period of progressive pancytopenia developed, necessitating transfusion of about 50 units of erythrocytes. On day 343 post-transplant, the patient presented with neutropenic fever and non-productive cough. Blood cultures yielded Streptococcus sanguis ii. A chest radiograph showed an infiltrate in the right lower lobe. Treatment with vancomycin, ceftazidim and penicillin was instituted with no response. Three days later (day 346), the patient suddenly died. The reticulum iron on a bone marrow smear at that time was strongly positive. Autopsy revealed pulmonary necrosis and thrombosis and an extending thrombus in the right atrium. Histological examination disclosed wide, thick-walled hyphae with few septa and right angle branching, positive on periodic-acid-Schiff staining. A diagnosis of pulmonary mucormycosis was made and confirmed by culture as Rhizopus species. Fungal hyphae were also seen in myocardial and esophageal biopsies.
Case 2
A 48-year-old male with chronic myeloid leukemia (first chronic phase) was transplanted from a partially HLAmatched family member. Cytosine-arabinoside toxicity, grade I graft-versus-host-disease and a poor recovery of the hematological parameters complicated the post-transplant period. Four months later (day 123) he was readmitted to hospital with non-neutropenic fever and pleuritic chest pain. Radiographic examination demonstrated an infiltrate in the left lower lobe and a left sinusitis maxillaris. Treatment with vancomycin, ceftazidim and acyclovir was started. Laboratory evaluation revealed a serum iron value of 224 g/dl, an iron binding capacity of 234 g/dl and a transferrin saturation of 95%. Iron staining of the bone marrow reticulum was strongly positive. The ferritin value was highly raised: 2030 g/l. Sixteen days later (day 139), the patient died due to progressive cardiorespiratory failure. Autopsy revealed pulmonary and myocardial necrosis, thrombosis and infarction. Histological examination showed a massive fungal invasion with emboli and a weak inflammatory response. Culture of the left ventricle thrombus yielded growth of loose filamentous, cottony-wide colonies at 37°C and 42°C. Morphologic examination disclosed hyaline, broad aseptate hyphae. Sporangiophores arose directly from rhizoids and bore spherical sporangia: compatible with a Rhizopus microsporus, rhizopodiformis variant.
Case 3
A 29-year-old woman with acute myeloid leukemia in first remission underwent an HLA-identical bone marrow transplant. Grade II acute graft-versus-host disease, cyclosporininduced hemolysis and a Staphylococcus epidermidis bacteraemia complicated the procedure. On day 90 after transplantation she was readmitted for hemoptysis, neutropenic fever, pleuritic chest pain and cough. Chest radiograph revealed an infiltration in the apex of the left lung, sugges- M = Male; F = female; ALL = acute lymphocytic leukaemia; AML = acute myelogenous leukaemia; CML = chronic myeloid leukaemia; Ara-C = cytosine-arabinoside; CY = cyclophosphamide; TBI = total body irradiation; GVHD = graft-versus-host disease; BMT = bone marrow transplantation; CMV = Cytomegalovirus; AmB = amphotericin B.
tive of invasive aspergillosis. An elevated iron level was demonstrated 2 weeks before: the serum iron value was 183 g/dl, with a total iron-binding capacity of 198 g/dl, a transferrin saturation of 92%, a ferritin value of 975 g/dl and strongly positive iron staining of the bone marrow reticulum. Her condition deteriorated rapidly despite the institution of broad-spectrum antibiotic therapy. Culture of the bronchial aspirate (taken during mechanical ventilation) yielded Rhizopus species and Saccharomyces cerevisiae.
Despite treatment with amphotericin B the patient died on day 113. Autopsy and culture from autopsy specimens confirmed the diagnosis of pulmonary mucormycosis.
Case 4
A 38-year-old male with acute myeloid leukemia entered complete remission after induction therapy and received a bone marrow transplant from his HLA-identical sister.
Acute and chronic graft-versus-host disease, mainly affecting liver and lungs (Bronchiolitis obliterans) complicated the procedure, for which the patient received steroids. Seventeen months after transplant, he was readmitted because of CMV infection. Two days later (day 605), a black, necrotic lesion developed near the exit site of the Hickman line. Periodic-acid-Schiff staining of a large cutaneous biopsy demonstrated extensive angio-invasion by broad aseptate hyphae with right angle branching, resulting in thrombi and tissue necrosis, and the presence of a marked acute neutrophil infiltrate. Culture of the biopsy yielded Rhizopus rhizopodiformis. Laboratory evaluation revealed a serum iron of 130 g/dl, an iron binding capacity of 143 g/dl and a saturation of 91%. The ferritin value was highly raised at 4045. A liver biopsy performed 2 months before admission and bone marrow reticulum were strongly positive on iron staining. Despite the administration of amphotericin B, the patient died due to multiorgan failure soon afterwards. Autopsy and culture from autopsy specimens identified disseminated aspergillosis as the major cause of death; there was no evidence of pulmonary or disseminated mucormycosis. In this particular case, we may conclude that a dual fungal infection was present.
Case 5
A 47-year-old male with AML M5 in second complete remission underwent an uneventful HLA-identical bone marrow transplant from his sister. Acute graft-versus-host disease did not occur, but 14 months post-transplant he developed mild liver dysfunction and oral lesions, compatible with chronic graft-versus-host disease. Three months after starting steroids (at tapering doses), the patient complained of abdominal cramps, dysphagia, pyrosis and weight loss (day 534). Endoscopic evaluation revealed a grade IV esophagitis with necrotic ulceration in the distal esophagus (from 30 to 40 cm) and a large gastric ulcer of 4-cm diameter. Biopsies taken from these lesions demonstrated the presence of a marked viral (CMV) and fungal invasion and a strong inflammatory response (epitheloid histiocytes, proliferating fibroblasts and mature granulocytes). The invading fungal population was heterogeneous, consisting of large, broad, non-septated PAS-positive hyphal elements with right angle branching (90°), yeast spores and fungi disclosing typical septate, acutely branching hyphae (possible Aspergillus species). However, despite the typical histopathological features of mucormycosis, a definite diagnosis was not obtained due to the absence of culture results. Because a pulmonary CAT scan demonstrated multiple small nodular lesions, bronchoscopic lavage was performed. Culture from the lavage fluid yielded CMV and antigen detection for Aspergillus was positive. Laboratory evaluation taken 6 weeks before revealed a serum iron value of 63 g/dl, a transferrin saturation of 81% and a high ferritin value of 1065 g/l. The patient was treated with amphotericin B, proton-pump inhibitors and ganciclovir. Endoscopic evaluation 3 weeks later showed marked improvement with a residual white lesion in the distal esophagus. New biopsies failed to reveal residual fungi. The patient was discharged home and remains well on itraconazole therapy.
Discussion
In contrast to reports of mucormycosis in diabetics, dialysis patients and leukemics, no patient in our series presented with infection at classical sites such as rhinocerebral, maxillofacial or sinonasal. Previously, Morrison and McGlave 10 also reported this apparent absence of 'typical' forms of mucormycosis in BMT recipients. However, this finding was not confirmed by a recent Italian analysis in thalassemics undergoing marrow transplantation. 11 Three of our patients presented with pulmonary involvement, either isolated or extending to contiguous organs. Widespread dissemination, a classical manifestation in neutropenic leukemia patients and mainly involving the lungs and central nervous system, was not seen in our series. Pulmonary disease complicated the early as well as late post-transplant course and seemed to be associated with acute graft-versus-host disease and its treatment (the use of steroids) or prolonged neutropenia. Mucormycosis was the primary cause of death in all three. Although cerebral autopsies were not been performed routinely, no patient demonstrated signs or symptoms of central nervous system involvement premortem.
In two patients, the late post-transplant episode was complicated by localized forms of mucormycosis that have not been reported in previous consecutive series in a similar study population. 10, 11 The first patient developed probable gastric mucormycosis, a condition exceptionally described in malnourished children, diabetics, renal and heart transplant recipients and AIDS patients. 12, 13 To our knowledge, isolated involvement of the stomach has never been reported in BMT recipients. Unexpectedly, the infection was successfully managed with amphotericin B and gastric proton pump inhibitors without the need for surgical intervention. The other patient was diagnosed with cutaneous mucor near the exit site of an indwelling line. Skin necrosis due to Mucorales is classically seen in severe burns or surgical wounds, sometimes acquired through the use of nonsterile bandages, but rarely in transplant patients. 14 Cutaneous mucormycosis may be rapidly progressive and requires surgical debridement for definite cure. Surprisingly, both 'limited' infections occurred during a period of steroid-treated chronic graft-versus-host disease. Furthermore, they were accompanied by the same pathogens: Aspergillus species and cytomegalovirus. In the only fatal case, death was not attributable to mucormycosis. Thus, the clinical spectrum of disease in BMT recipients seems to differ from that in other populations at risk. Patients with localized mucormycosis represent a more favorable subgroup since they can be additionally treated by aggressive surgical debridement.
Several well-known risk factors for mucormycosis such as prolonged, profound neutropenia, prolonged use of corticosteroids and (steroid-induced) diabetes mellitus are usually present in marrow transplant recipients. 2 However, three of our patients had normal neutrophil counts when the infection developed. They were all treated with steroids and two of them developed steroid-induced diabetes mellitus after BMT. Although none of our patients had been splenectomized, Ingram et al 5 have described previous splenectomy as a co-risk factor. The role of iron overload as another possible co-risk factor has seldom been evalu-ated in this population. Our retrospective case-control analysis suggests that transfusional iron overload may indeed play a role in the development of mucormycosis following transplantation. In each of the five patients iron overload was confirmed by high serum iron levels, totally saturated transferrin, high serum ferritin scores and/or the demonstration of massive iron storage in bone marrow, liver and/or spleen. Furthermore, these parameters were significantly higher than in matched controls not developing invasive mucormycosis.
Compared to previous reports in dialysis patients, our series is noteworthy in several respects: First, classical risk factors for the development of mycotic infections were present in all five cases (100%) while these predisposing factors were not withheld in 70% of cases reported to an international registry of mucormycosis in maintenance dialysis. 9 Second, none of our patients ever received any form of chelation therapy, an association found in 78% of the dialysis cases. 9 This striking association between the occurrence of mucormycosis and use of deferoxamine (DFO) in the treatment of aluminium and to a lesser extent iron overload in patients on dialysis has prompted several investigators to study the possible pathogenic effect of DFO. Van Cutsem et al 15 hypothesized that the enhancement of experimentally induced mucormycosis in healthy guinea pigs after administration of DFO, Fe 3ϩ citrate or both was mediated through the in vivo formation of the iron-chelate of DFO, feroxamine, for which fungi may have a receptor. As such, DFO could function as a siderophore, providing iron to promote the growth and sporulation of Rhizopus strains. In vitro studies on fungal growth and radioiron uptake after stimulation by iron-chelated DFO support this hypothesis. 15, 16 Apparently, the ability to use feroxamine as a source of iron is not shared by other filamentous fungi such as A. fumigatus. 17 The higher susceptibility of dialysis vs hematological patients was further explained by the prolonged accumulation of serum feroxamine in dialysis patients due to pharmacokinetic alterations in renal failure. 18 However, as already mentioned, none of our patients received chelation therapy before or at the time of development of mucormycosis. Finally, Boelaert et al 9 noted that less than one third of the DFO-treated renal patients who developed mucormycosis had iron overload compared to 100% in our series (based on the same criteria). Consequently, these authors argued that a hemochromatotic condition was not a prerequisite for the development of these mycoses. However, we believe that iron overload may play an important role in the pathogenesis of mucormycosis in BMT recipients, although other factors also remain important. A number of experimental studies have linked iron availability and host susceptibility to some pathogenic micro-organisms, including Mucorales. Iron adversely affects the phagocytic, chemotactic and bactericidal capacity of neutrophils and monocytes and has been observed to inhibit the activity of natural killer cells and macrophages. 19, 20 On the other hand, iron enhances the ability of microbes to grow in host cells, tissues and fluids. 21 However, in human plasma or on mucosal surfaces, the amount of free iron accessible for microbial invaders is very low. Almost all of the iron is bound to high affinity proteins, such as transferrin in the serum and lactoferrin in the neutrophils or locked in tissue stores, the so-called 'iron withholding defense system'. 19 Nevertheless, some pathogens such as Streptomyces and Nocardia have evolved complex mechanisms to compete for iron in the host, usually by secreting siderophores, which trap iron and deliver it to the microbial species as a nutrient. 22, 23 In a low iron medium, Mucoraceae too have been shown to produce minimal amounts of a hydroxamate-type siderophore. 24 Additional data have suggested that changes in the iron availability to the fungus are involved in the pathogenesis of mucormycosis.
First, mucormycosis has developed in anephric patients with evidence of transfusional iron overload not receiving chelation therapy or having other risk factors for invasive mycoses. 25 Second, in experimental animal models, the addition of Fe 3ϩ citrate shortens survival of the infected animals after challenge with agents of mucormycosis. 17 Third, a larger number of animals injected with Absidia spores died when the spores were prepared in an iron-containing solution. 26 Finally, several authors have suggested that acidosis, a condition frequently associated with mucormycosis, probably does not play a primary role but acts by decreasing the iron binding capacity of serum transferrin and hence by partially reversing the normal fungistatic action of serum and cerebrospinal fluid. [27] [28] [29] We believe that a high level of serum transferrin saturation, following the exogenous administration of large amounts of iron through polytransfusion of erythrocytes, leads to the presence of non-transferrin bound serum iron. As such, an abnormally large iron fraction becomes readily available as growth factor for agents of mucormycosis and must be seen as an additional risk factor next to neutropenia, the use of steroids and deficient humoral immunity. Since the metal chelator DFO might have the potential to act as a siderophore, its use should not be recommended to treat iron overload in transplant patients, irrespective of renal function. 16 As noted in other reports of mucormycosis, mortality from these infections is dramatically high. Therapy consists of correction of predisposing conditions (eg diabetic ketoacidosis, immunosuppressive drugs), extensive surgical debridement of devitalised tissue and long-term antifungal therapy. At present, conventional amphotericin B or a liposomal preparation remain the mainstay of antifungal therapy. Azole derivates (both fluconazole and itraconazole) have no place in prophylaxis or therapy against Mucorales. 30 The role of additional measures such as hyperbaric oxygen, growth factors and granulocyte transfusions is debatable and only based on anecdotal evidence.
In conclusion, although the incidence may be slightly increasing, mucormycosis remains a rarity among allogeneic bone marrow transplant recipients. This mycosis may complicate the early as well as late post-transplant course and is not confined exclusively to neutropenics. The spectrum of disease seems to differ from that seen in other risk groups. From experimental work and observational data, it appears that iron overload, either transfusional or due to dyserythropoiesis, may be an important co-risk factor in the development of mucormycosis in this patient population.
